Rarres1 inhibitors are a class of chemical compounds designed to target and inhibit the function of Rarres1 (Retinoic Acid Receptor Responder 1), a protein involved in a variety of cellular processes, including differentiation and metabolism. Rarres1 was originally identified as a gene induced by retinoic acid and has since been associated with roles in regulating cell growth and response to external signals. It is thought to influence pathways involved in cell adhesion and possibly the remodeling of the extracellular matrix. Rarres1 is also implicated in processes related to the control of cell differentiation and tissue-specific functions, particularly in the context of retinoic acid signaling, which modulates key developmental and physiological processes. Inhibitors of Rarres1 function by binding to the protein or interfering with its interactions with other molecules, disrupting its regulatory effects on cellular activities.
The inhibition of Rarres1 leads to alterations in cellular processes that depend on its regulatory functions, particularly in relation to cell differentiation and the organization of the extracellular environment. By blocking Rarres1 activity, these inhibitors can impact pathways that involve cell growth, adhesion, and interactions with the extracellular matrix, which are essential for maintaining tissue structure and function. Researchers use Rarres1 inhibitors to study the precise role of this protein in retinoic acid signaling pathways and to better understand how it influences cellular behavior in response to environmental and developmental cues. These inhibitors are also valuable tools for exploring how Rarres1 interacts with other proteins and signaling molecules to regulate complex biological processes. The study of Rarres1 inhibitors helps to uncover the broader mechanisms through which retinoic acid and its downstream effectors modulate gene expression, tissue architecture, and cellular differentiation, contributing to a deeper understanding of molecular regulation in various biological systems.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
A retinoic acid analog that modulates retinoic acid receptor activity, potentially influencing RARRES1 expression. | ||||||
13-cis-Retinoic acid | 4759-48-2 | sc-205568 sc-205568A | 100 mg 250 mg | $74.00 $118.00 | 8 | |
A synthetic retinoid affecting cell proliferation and differentiation, indirectly impacting RARRES1 levels. | ||||||
Bexarotene | 153559-49-0 | sc-217753 sc-217753A | 10 mg 100 mg | $54.00 $245.00 | 6 | |
A synthetic retinoid specifically targeting RXR receptors, which may alter RARRES1 expression through retinoid pathways. | ||||||
BKM120 | 944396-07-0 | sc-364437 sc-364437A sc-364437B sc-364437C | 5 mg 10 mg 25 mg 50 mg | $173.00 $230.00 $275.00 $332.00 | 9 | |
A synthetic retinoid with selective activity on RAR, potentially modulating RARRES1 through altered retinoic acid signaling. | ||||||
4-Hydroxyphenylretinamide | 65646-68-6 | sc-200900 sc-200900A | 5 mg 25 mg | $104.00 $315.00 | ||
A synthetic retinoid with potential to influence RARRES1 expression by modulating retinoid signaling and apoptosis. | ||||||
Adapalene | 106685-40-9 | sc-203803 sc-203803A | 10 mg 50 mg | $65.00 $325.00 | 2 | |
A synthetic analogue of retinoic acid, acting on retinoid receptors with potential indirect effects on RARRES1. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
A CDK4/6 inhibitor that may indirectly affect RARRES1 expression by altering cell cycle and differentiation. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
A HDAC inhibitor that can influence gene expression broadly, potentially affecting RARRES1 levels. | ||||||
Tazarotene | 118292-40-3 | sc-220193 | 10 mg | $103.00 | ||
A prodrug of tazarotenic acid, specifically modulating retinoic acid receptor activity, which could indirectly affect RARRES1. | ||||||
9-cis-Retinoic acid | 5300-03-8 | sc-205589 sc-205589B sc-205589C sc-205589D sc-205589A | 1 mg 25 mg 250 mg 500 mg 5 mg | $70.00 $416.00 $3060.00 $5610.00 $145.00 | 10 | |
A pan-retinoic acid receptor agonist, potentially modulating RARRES1 expression through broad retinoid activity. | ||||||